Sorafenib/SBRT Yields OS Benefit in Locally Advanced Hepatocellular Carcinoma

被引：0
|
作者：
Seymour, Caroline
机构：
来源：
ONCOLOGY-NEW YORK | 2023年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [1] SBRT compared to sorafenib in locally advanced hepatocellular carcinoma: a propensity score analysis
    Gkika, E.
    Brunner, T.
    Abbasi-Senger, N.
    Alheit, H.
    Baus, W.
    Blanck, O.
    Gerum, S.
    Guckenberger, M.
    Habermehl, D.
    Ostheimer, C.
    Riesterer, O.
    Tamihardja, J.
    Pinato, D. J.
    Rimassa, L.
    Pressiani, T.
    Schultheiss, M.
    Sharma, R.
    Burlone, M. E.
    Pirisi, M.
    Kudo, M.
    Park, J. W.
    Neumann-Haefelin, C.
    Grosu, A.
    Thimme, R.
    Bettinger, D.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S423 - S423
  • [2] COST EFFECTIVENESS OF SORAFENIB VERSUS SBRT FOR ADVANCED HEPATOCELLULAR CARCINOMA
    Chan, A.
    Leung, H.
    VALUE IN HEALTH, 2016, 19 (03) : A152 - A152
  • [3] Phase I Study of Sorafenib and SBRT for Advanced Hepatocellular Carcinoma
    Dawson, L. A.
    Brade, A.
    Cho, C.
    Kim, J.
    Brierley, J.
    Dinniwell, R.
    Wong, R.
    Ringash, J.
    Cummings, B.
    Knox, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S10 - S11
  • [4] Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
    Henry W. C. Leung
    Chung-Feng Liu
    Agnes L. F. Chan
    Radiation Oncology, 11
  • [5] Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
    Leung, Henry W. C.
    Liu, Chung-Feng
    Chan, Agnes L. F.
    RADIATION ONCOLOGY, 2016, 11
  • [6] Complete regression following sorafenib in unresectable, locally advanced hepatocellular carcinoma
    Moroni, Marco
    Zanlorenzi, Laura
    FUTURE ONCOLOGY, 2013, 9 (08) : 1231 - 1237
  • [7] Sorafenib in advanced hepatocellular carcinoma
    Sauerbruch, T.
    Gonzalez-Carmona, A. M.
    Nitschmann, S.
    INTERNIST, 2009, 50 (11): : 1290 - 1292
  • [8] Sorafenib in advanced hepatocellular carcinoma
    Llovet, Josep M.
    Ricci, Sergio
    Mazzaferro, Vincenzo
    Hilgard, Philip
    Gane, Edward
    Blanc, Jean-Frederic
    Cosme de Oliveira, Andre
    Santoro, Armando
    Raoul, Jean-Luc
    Forner, Alejandro
    Schwartz, Myron
    Porta, Camillo
    Zeuzem, Stefan
    Bolondi, Luigi
    Greten, Tim F.
    Galle, Peter R.
    Seitz, Jean-Francois
    Borbath, Ivan
    Haussinger, Dieter
    Giannaris, Tom
    Shan, Minghua
    Moscovici, Marius
    Voliotis, Dimitris
    Bruix, Jordi
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04): : 378 - 390
  • [9] Sorafenib for Advanced Hepatocellular Carcinoma
    Shingina, Alexandra
    Hashim, ALMoutaz
    Haque, Mazhar
    Suen, Michael W.
    Yoshida, Eric M.
    Gill, Sharlene
    Weiss, Alan
    GASTROENTEROLOGY, 2012, 142 (05) : S42 - S42
  • [10] Complete Regression of Locally Advanced Hepatocellular Carcinoma (HCC) Following Sorafenib Monotherapy
    Kumar, Shiva
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S374 - S374
12345